InvestorsHub Logo
Followers 54
Posts 4438
Boards Moderated 0
Alias Born 08/21/2015

Re: Darkoo post# 20670

Tuesday, 04/25/2017 12:07:44 PM

Tuesday, April 25, 2017 12:07:44 PM

Post# of 73508
That's Otiko's defense as presented in writing to shareholders. There is so much written evidence in Otiko's news releases and financials, along with the website claims that Diabecline was their Lead Product in February 2017, that can be used against him.

Anyone can call the USPTO, as I did, and learn there is an active dispute, no Final Action, or simply look at the Transaction History displayed below.



Keough ABANDONED patents, forfeiting IP and contracts. Addendum signed between Phillips and Otiko. NOTHING TO WORRY ABOUT IMO. $$$ Coming by end of year